Akero Therapeutics Announces $70 Million in New Financing

New Financing to Advance Therapeutic Pipeline for NASH, Serious Metabolic…


Akero Therapeutics Appoints Mark Iwicki to its Board of Directors

Iwicki is chairman and CEO of Kala Pharmaceuticals San Francisco, CA –…


Kitty Yale

Akero Therapeutics Expands Leadership Team

Kitty Yale Appointed Chief Development Officer San Francisco, CA – Akero…


Andrew Cheng, MD, PhD

Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer

Akero’s lead program AKR-001 to advance into Phase 2 clinical studies in…